CTMX
CytomX Therapeutics, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-16
Figures on this page computed 2026-11-08 12:40 UTC
Last close
2.35USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-03-16
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-107146
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-16
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-107146
- Reported in
- USD
- 10-K for 2025, filed 2026-03-16
- 10-K for 2025, filed 2026-03-16
- 10-K for 2025, filed 2026-03-16
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-03-16
- 10-Q for 2025, filed 2026-08-06
-22.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-107146
- Reported in
- USD
- 10-K for 2025, filed 2026-03-16
- 10-K for 2025, filed 2026-03-16
-99.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-107146
- Reported in
- USD
- 10-K for 2025, filed 2026-03-16
- 10-K for 2025, filed 2026-03-16
0.04Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-107146
- Reported in
- USD
- 10-K for 2025, filed 2026-03-16
- 10-Q for 2025, filed 2026-08-06
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.17 against 0.50 on the market's range.
- Growth2.2%17 of 100, below its sector
- Returns on capital-17.5%29 of 100, above its sector
- Margins-29.4%21 of 100, below its sector
- Price3.0x29 of 100, below its sector
- Safety0.0458 of 100, at its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
What it sells, to whom
lens 8 of 9The filer tagged nothing for this, so there is nothing filed to draw.
Nothing is drawn in its place. The other lenses are unaffected.
This filer discloses concentration of risk in the notes as prose and did not tag the percentages, so there is no machine-readable figure to show. Read the note in the filing.